Ascensia Diabetes Care signs MOU to transfer Eversense CGM distribution to Senseonics

Ascensia Diabetes Care signed a memorandum of understanding to transfer commercial operations for Eversense Continuous Glucose Monitoring systems to Senseonics Holdings. The transfer is targeted for January 1, 2026, subject to a definitive agreement.

“Unifying development, manufacturing, and distribution within Senseonics would enable Eversense to accelerate growth and realize its full potential faster than under the current structure.”markets.financialcontent.com

• 1 source
• markets.financialcontent.comAscensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner SenseonicsPHC Holdings CorporationSep 3, 2025

Summarized from public sources; check the original articles before acting on it.